An in vitro model for the growth and analysis of chronic wound MRSA biofilms

被引:40
作者
Agostinho, A. M. [1 ]
Hartman, A. [1 ]
Lipp, C. [1 ]
Parker, A. E. [1 ]
Stewart, P. S. [1 ]
James, G. A. [1 ]
机构
[1] Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA
关键词
antimicrobial agents; biofilms; chronic wounds; in vitro model; MRSA; SUSCEPTIBILITIES; PENETRATION; RESISTANCE; DRESSINGS; BACTERIA; SILVER; ULCERS; IMPACT;
D O I
10.1111/j.1365-2672.2011.05138.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aims: To develop an in vitro model (Colony/drip-flow reactor - C/DFR) for the growth and analysis of methicillin-resistant Staphylococcus aureus (MRSA) biofilms. Methods and Results: Using the C/DFR model, biofilms were grown on the top of polycarbonate filter membranes inoculated with a clinical isolate of MRSA, placed on absorbent pads in the DFR and harvested after 72 h. The biofilms varied from 256 to 308 mu m in thickness with a repeatability standard deviation of 0.22. Testing of antimicrobial agents was also performed where C/DFR biofilms were grown in parallel with conventional colony biofilms. A saline solution (control), 1% silver sulfadiazine solution, and 0.5% Dakin's solution were used to treat the biofilms for 15 min. Microscopic evaluation of biofilm morphology and thickness was conducted. The Dakins solution in both models produced statistically significantly higher log reductions than silver sulfadiazine treatment. Conclusions: The C/DFR biofilms were thick and repeatable and exhibited higher resistance to Dakins solution than the treated colony biofilms. Significance and Impact of the Study: The C/ DFR can be used as a tool for examining complex biofilm physiology as well as for performing comparative experiments that test wound care products and novel antimicrobials.
引用
收藏
页码:1275 / 1282
页数:8
相关论文
共 35 条
[1]  
American Diabetes Association, 1999, Diabetes Care, V22, P1354
[2]   Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin [J].
Anderl, JN ;
Franklin, MJ ;
Stewart, PS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) :1818-1824
[3]  
[Anonymous], STAT COMPUTING
[4]  
[Anonymous], BIOFOULING
[5]  
[Anonymous], Diabetes Public Health Resource
[6]   Why chronic wounds will not heal: a novel hypothesis [J].
Bjarnsholt, Thomas ;
Kirketerp-Moller, Klaus ;
Jensen, Peter Ostrup ;
Madsen, Kit G. ;
Phipps, Richard ;
Krogfelt, Karen ;
Hoiby, Niels ;
Givskov, Michael .
WOUND REPAIR AND REGENERATION, 2008, 16 (01) :2-10
[7]   Silver against Pseudomonas aeruginosa biofilms [J].
Bjarnsholt, Thomas ;
Kirketerp-Moller, Klaus ;
Kristiansen, Soren ;
Phipps, Richard ;
Nielsen, Anne Kirstine ;
Jensen, Peter Ostrup ;
Hoiby, Niels ;
Givskov, Michael .
APMIS, 2007, 115 (08) :921-928
[8]  
Brown D L, 1999, Ostomy Wound Manage, V45, p109S
[9]   Comparative evaluation of biofilm disinfectant efficacy tests [J].
Buckingham-Meyer, Kelli ;
Goeres, Darla M. ;
Hamilton, Martin A. .
JOURNAL OF MICROBIOLOGICAL METHODS, 2007, 70 (02) :236-244
[10]   The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms [J].
Ceri, H ;
Olson, ME ;
Stremick, C ;
Read, RR ;
Morck, D ;
Buret, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) :1771-1776